Hi Jack,
I'll get back to you during the week with what I find
Meanwhile, a form 41 was most probably filed with the BCSC
STATEMENT OF EXECUTIVE COMPENSATION
[....]
A few definitions
"replacement grant" of an option or SAR means the grant of an option or SAR
reasonably related to any prior or potential cancellation of an option or SAR,
whether by,
(a) an exchange of existing options or SARs for options or SARs with new terms,
(b) the grant of new options or SARs designed to operate in tandem with previously
granted options or SARs that upon exercise will operate to cancel the previously
granted options or SARs,
(c) downward repricing of previously granted options or SARs, or
(d) any other means;
"repricing" of an option or SAR means the adjustment or amendment of the exercise
or base price of an option or SAR previously awarded, whether through amendment,
cancellation or replacement grants, or any other means, but does not include any
repricing occurring through the operation of a formula or mechanism in, or applicable
to, the previously awarded option or SAR that results in the periodic adjustment of
the effective exercise, purchase or base price, a plan anti-dilution provision, or a
recapitalization or similar transaction equally affecting all holders of the class of
securities underlying the option or SAR and "repriced" has a corresponding meaning;
M V Option and SAR Repricings
V.1 If at any time after October 31, 1993 and during the most recently completed financial year,
the issuer has repriced downward any options or freestanding SARs held by any Named
Executive Officer, state the information specified in Subitem V.2 concerning all downward
repricings of options or SARs held by executive officers of the issuer during the shorter of,
(a) the 10 year period ending on the date of certification of the disclosure required by
this Form, and
(b) the period during which the issuer has been a reporting issuer,
in the tabular form under the caption set out below.
TABLE OF OPTION AND SAR REPRICINGS
_____________________________________________________________________________________
Length of
Market Original
Price of Exercise Option Term
Securities Under Securities at Price at Remaining at
Options/SARs Time of Time of New Date of
Date of Repriced or Repricing or Repricing or Exercise Repricing or
Name Repricing Amended Amendment Amendment Price Amendment
(#) ($/Security) ($/Security) ($/Security)
(a) (b) (c) (d) (e) (f) (g)
_____________________________________________________________________________________
_____________________________________________________________________________________
V.2 The table required by Subitem V.1 must include, for each downward repricing:
(a) The name and position of the executive officer (column (a)).
(b) The date of repricing (column (b)).
(c) The number of securities underlying replacement or amended options or SARs
(column (c)).
(d) The per-security market price of the underlying security at the time of repricing
(column (d)).
(e) The original per-security exercise price or base price of the cancelled or amended
option or SAR (column (e)).
(f) The per-security exercise price or base price of the replacement option or SAR
(column (f)),
(g) The amount of time remaining before the replaced or amended option or SAR
would have expired (column (g)).
V.3 For the Table required by Subitem V.1:
(a) Information about a replacement grant made during the financial year must be
disclosed even if the corresponding original grant was cancelled in a prior year.
(b) If the replacement grant is not made at the current market value, describe this fact
and the terms of the grant in a footnote or accompanying textual narrative.
(c) The information must be presented in groups according to issuer and class or
series of security underlying options or SARs and within these groups in reverse
chronological order.
V.4 In a narrative immediately before or after the table required by this Item, explain in reasonable
detail the basis for all downward repricings during the most recently completed financial year of
options and SARs held by any of the Named Executive Officers.
|
